Premature premature ejaculation started more than forty years ago. At that time, the side effects of ejaculation latency appeared in the clinical application of antidepressant drugs. Under the inspiration of this phenomenon, reports on various anti -psychiatric drug treatment of premature ejaculation were subsequently followed. Come, most of these reports are small studies or poorly designed small studies.In recent years, more and more research on the treatment of antidepressants has been used to treat premature ejaculation, and greater and better clinical experimental reports have also emerged.Antidepressants have now become commonly used drugs for treating premature ejaculation. The mechanism of treating premature ejaculation is mostly related to increasing the content of large brain center 5-hydroxylin.
Chloropyzine
Chloropyrazine is one of the earliest antidepressants for the treatment of premature ejaculation, but its drug side effects are more prominent. Common gastrointestinal reactions such as nausea and vomiting, and other sidelines and drowsiness.It has now been replaced by drugs with more special effects and smaller side effects.
Selective 5-hydroxylin re-intake inhibitors
In recent years, selective 5-hydroxyline re-intake inhibitors have been widely valued and studied. Compared with placebo, taking Fluustine, Palosein or Shequlin every day can significantly delay ejaculation. Generally, antidepressant drugs are taken every day. It can achieve the effect of ejaculation delay in about 5 to 10 days.It takes good effect when using a selective 5-hydroxylidine re-intake inhibitors, and patients will not be nervous because they are looking forward to sexual intercourse.Although the daily selective 5-hydroxylin re-intake inhibitor increases the patient's medication, the side effects of selective 5-hydroxylidine reenginer inhibitors are relatively mild.
(Editor in charge: Internship Zhang Yiwen)
